Roctavian FDA Approval Status
Last updated by Judith Stewart, BPharm on July 9, 2020.
Roctavian (valoctocogene roxaparvovec) is an investigational gene therapy in development for the treatment of hemophilia A.
Development timeline for Roctavian
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.